HeartFlow, Inc. (HTFL)
47.38
-2.79
(-5.56%)
USD |
NASDAQ |
Sep 23, 16:00
47.52
+0.14
(+0.30%)
After-Hours: 20:00
HeartFlow Enterprise Value : 4.215B for Sept. 22, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 22, 2026 | 4.215B |
| September 21, 2026 | 4.229B |
| September 18, 2026 | 4.265B |
| September 17, 2026 | 4.163B |
| September 16, 2026 | 4.053B |
| September 15, 2026 | 4.056B |
| September 14, 2026 | 4.161B |
| September 11, 2026 | 4.190B |
| September 10, 2026 | 3.809B |
| September 09, 2026 | 3.912B |
| September 08, 2026 | 4.005B |
| September 04, 2026 | 4.106B |
| September 03, 2026 | 4.175B |
| September 02, 2026 | 4.200B |
| September 01, 2026 | 4.238B |
| August 31, 2026 | 4.234B |
| August 28, 2026 | 4.008B |
| August 27, 2026 | 4.036B |
| August 26, 2026 | 4.109B |
| August 25, 2026 | 4.191B |
| August 24, 2026 | 4.218B |
| August 21, 2026 | 4.179B |
| August 20, 2026 | 3.923B |
| August 19, 2026 | 3.813B |
| August 18, 2026 | 3.787B |
| Date | Value |
|---|---|
| August 17, 2026 | 3.502B |
| August 14, 2026 | 3.514B |
| August 13, 2026 | 2.554B |
| August 12, 2026 | 2.453B |
| August 11, 2026 | 2.426B |
| August 10, 2026 | 2.410B |
| August 07, 2026 | 2.364B |
| August 06, 2026 | 2.222B |
| August 05, 2026 | 2.221B |
| August 04, 2026 | 2.230B |
| August 03, 2026 | 2.185B |
| July 31, 2026 | 2.052B |
| July 30, 2026 | 2.104B |
| July 29, 2026 | 2.036B |
| July 28, 2026 | 2.084B |
| July 27, 2026 | 2.065B |
| July 24, 2026 | 1.956B |
| July 23, 2026 | 1.999B |
| July 22, 2026 | 1.966B |
| July 21, 2026 | 2.071B |
| July 20, 2026 | 1.994B |
| July 17, 2026 | 2.022B |
| July 16, 2026 | 2.117B |
| July 15, 2026 | 2.228B |
| July 14, 2026 | 2.075B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Biotricity, Inc. | 32.03M |
| Aclarion, Inc. | -9.835M |
| Iovance Biotherapeutics, Inc. | 4.568B |
| Retrieve Medical Holdings, Inc. | 29.44M |
| Boston Scientific Corp. | 77.20B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -15.74M |
| Revenue (Quarterly) | 64.08M |
| Total Expenses (Quarterly) | 79.82M |
| EPS Diluted (Quarterly) | -0.1822 |
| Gross Profit Margin (Quarterly) | 83.00% |
| Profit Margin (Quarterly) | -24.57% |
| Earnings Yield | -2.95% |
| Normalized Earnings Yield | -2.063 |